001     912181
005     20230929112459.0
024 7 _ |2 doi
|a 10.1016/j.toxlet.2022.11.018
024 7 _ |2 ISSN
|a 0378-4274
024 7 _ |2 ISSN
|a 1879-3169
024 7 _ |2 Handle
|a 2128/32994
024 7 _ |a 36503818
|2 pmid
024 7 _ |a WOS:000928240000002
|2 WOS
037 _ _ |a FZJ-2022-05397
082 _ _ |a 610
100 1 _ |0 P:(DE-HGF)0
|a Kaiser, Jesko
|b 0
245 _ _ |a A novel binding site in the nicotinic acetylcholine receptor for MB327 can explain its allosteric modulation relevant for organophosphorus-poisoning treatment
260 _ _ |a Amsterdam [u.a.]
|b Elsevier Science
|c 2023
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1675250275_9369
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
520 _ _ |a Organophosphorus compounds (OPCs) are highly toxic compounds that can block acetylcholine esterase (AChE) and thereby indirectly lead to an overstimulation of muscarinic and nicotinic acetylcholine receptors (nAChRs). The current treatment with atropine and AChE reactivators (oximes) is insufficient to prevent toxic effects, such as respiratory paralysis, after poisonings with various OPCs. Thus, alternative treatment options are required to increase treatment efficacy. Novel therapeutics, such as the bispyridinium non-oxime MB327, have been found to reestablish neuromuscular transmission by interacting directly with nAChR, probably via allosteric mechanisms. To rationally design new, more potent drugs addressing nAChR, knowledge of the binding mode of MB327 is fundamental. However, the binding pocket of MB327 has remained elusive. Here, we identify a new potential allosteric binding pocket (MB327-PAM-1) of MB327 located at the transition of the extracellular to the transmembrane region using blind docking experiments and molecular dynamics simulations. MB327 forms striking interactions with the receptor at this site. The interacting amino acids are highly conserved among different subunits and different species. Correspondingly, MB327 can interact with several nAChR subtypes from different species. We predict by rigidity analysis that MB327 exerts an allosteric effect on the orthosteric binding pocket and the transmembrane domain after binding to MB327-PAM-1. Furthermore, free ligand diffusion MD simulations reveal that MB327 also has an affinity to the orthosteric binding pocket, which agrees with recently published results that related bispyridinium compounds show inhibitory effects via the orthosteric binding site. The newly identified binding site allowed us to predict structural modifications of MB327, resulting in the more potent resensitizers PTM0062 and PTM0063.
536 _ _ |0 G:(DE-HGF)POF4-5111
|a 5111 - Domain-Specific Simulation & Data Life Cycle Labs (SDLs) and Research Groups (POF4-511)
|c POF4-511
|f POF IV
|x 0
536 _ _ |0 G:(DE-Juel1)hkf7_20200501
|a Forschergruppe Gohlke (hkf7_20200501)
|c hkf7_20200501
|f Forschergruppe Gohlke
|x 1
536 _ _ |0 G:(DE-HGF)POF4-5241
|a 5241 - Molecular Information Processing in Cellular Systems (POF4-524)
|c POF4-524
|f POF IV
|x 2
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |0 P:(DE-HGF)0
|a Gertzen, Christoph G. W.
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Bernauer, Tamara
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Höfner, Georg
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Niessen, Karin V.
|b 4
700 1 _ |0 P:(DE-HGF)0
|a Seeger, Thomas
|b 5
700 1 _ |0 P:(DE-HGF)0
|a Paintner, Franz F.
|b 6
700 1 _ |0 P:(DE-HGF)0
|a Wanner, Klaus T.
|b 7
700 1 _ |0 P:(DE-HGF)0
|a Worek, Franz
|b 8
700 1 _ |0 P:(DE-HGF)0
|a Thiermann, Horst
|b 9
700 1 _ |0 P:(DE-Juel1)172663
|a Gohlke, Holger
|b 10
|e Corresponding author
773 _ _ |0 PERI:(DE-600)1500784-4
|a 10.1016/j.toxlet.2022.11.018
|g p. S0378427422018008
|p 160-171
|t Toxicology letters
|v 373
|x 0378-4274
|y 2023
856 4 _ |u https://juser.fz-juelich.de/record/912181/files/Paper_MB327_bindingsite_EJMC_revision_final.pdf
|y Published on 2022-11-26. Available in OpenAccess from 2023-11-26.
909 C O |o oai:juser.fz-juelich.de:912181
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)172663
|a Forschungszentrum Jülich
|b 10
|k FZJ
913 1 _ |0 G:(DE-HGF)POF4-511
|1 G:(DE-HGF)POF4-510
|2 G:(DE-HGF)POF4-500
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|9 G:(DE-HGF)POF4-5111
|a DE-HGF
|b Key Technologies
|l Engineering Digital Futures – Supercomputing, Data Management and Information Security for Knowledge and Action
|v Enabling Computational- & Data-Intensive Science and Engineering
|x 0
913 1 _ |0 G:(DE-HGF)POF4-524
|1 G:(DE-HGF)POF4-520
|2 G:(DE-HGF)POF4-500
|3 G:(DE-HGF)POF4
|4 G:(DE-HGF)POF
|9 G:(DE-HGF)POF4-5241
|a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|v Molecular and Cellular Information Processing
|x 1
914 1 _ |y 2023
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
|0 LIC:(DE-HGF)CCBYNCND4
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-11
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-08-23
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-23
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b TOXICOL LETT : 2022
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-23
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-23
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-08-23
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)NIC-20090406
|k NIC
|l John von Neumann - Institut für Computing
|x 0
920 1 _ |0 I:(DE-Juel1)JSC-20090406
|k JSC
|l Jülich Supercomputing Center
|x 1
920 1 _ |0 I:(DE-Juel1)IBI-7-20200312
|k IBI-7
|l Strukturbiochemie
|x 2
920 1 _ |0 I:(DE-Juel1)IBG-4-20200403
|k IBG-4
|l Bioinformatik
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)NIC-20090406
980 _ _ |a I:(DE-Juel1)JSC-20090406
980 _ _ |a I:(DE-Juel1)IBI-7-20200312
980 _ _ |a I:(DE-Juel1)IBG-4-20200403
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21